A day after Mylan was one of six pharmaceutical companies named in a multi-state lawsuit alleging price-fixing on generic drugs, the maker of high-priced emergency allergy treatment EpiPen announced that the generic version of the popular epinephrine auto-injector is finally hitting the market, giving people a lower-cost (but still pricey) option for buying the drug. [More]
